A world-class, state-of-the-art process research facility was launched in Cherrywood, Dublin today with the announcement of 100 new jobs at Irish pharmaceutical research company APC.
APC is an innovator in process research solutions for the drugs industry, helping global clients accelerate the development of their medicines for a wide range of conditions including cancer and HIV.
Speaking at the launch, An Taoiseach Enda Kenny TD, said: “I am delighted to welcome the announcement by APC of 100 new jobs in Dublin. This new research centre is a vote of confidence in Ireland and enhances our reputation as a leading location for pharmaceutical research and development. It is also a shining example of how a thriving business can grow from a bright idea once the right conditions are created by the right Government policies.”
Launched by Mark Barrett and Brian Glennon in the middle of the financial crisis, APC found a way to help pharmaceutical industry make complex new medicines reliably, and at scale, both here in Ireland and abroad.
The company now partners with eight of the top 10 pharmaceutical and five of the top 10 biotech firms in the world and the company aims to reach revenues of €50m by 2020.
Mark Barrett, CEO, APC, commented: “Turning a wonder molecule into a mass-produced medicine presents serious scientific and technological challenges even for some of the largest companies in the world. In our research, Brian and I saw an opportunity.”
Barrett continued: “Our success has come from working with talented and creative engineers and scientists. We need people who enjoy the rewards of working in an environment that is driven by cutting-edge technology and science. In return, we will provide them with an opportunity to do something extraordinary: to help change patient outcomes for the better.”